The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells
Abstract
In this paper, a targeted drug delivery system has been developed based on hyaluronic acid (HA) modified mesoporous silica nanoparticles (MSNs). HA-MSNs possess a specific affinity to CD44 over-expressed on the surface of a specific cancer cell line, HCT-116 (human colon cancer cells). The cellular uptake performance of fluorescently labelled MSNs with and without HA modification has been evaluated by confocal microscopy and fluorescence-activated cell sorter (FACS) analysis. Compared to bare MSNs, HA-MSNs exhibit a higher cellular uptake via HA receptor mediated endocytosis. An anticancer drug, doxorubicin hydrochloride (Dox), has been loaded into MSNs and HA-MSNs as drug delivery vehicles. Dox loaded HA-MSNs show greater cytotoxicity to HCT-116 cells than free Dox and Dox-MSNs due to the enhanced cell internalization behavior of HA-MSNs. It is expected that HA-MSNs have a great potential in targeted delivery of anticancer drugs to CD44 over-expressing tumors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyaluronic acid is a polysaccharide that has a high affinity for CD44 receptors, which is overexpressed in many tumours including colorectal cancer.111”
From Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment (2022) · cites this paper as [111]
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Research works printed but not linked: 31
- Kim, 2010, N. Engl. J. Med., 363, 2434, 10.1056/NEJMra0912273 · DOI
- Huang, 2011, J. Controlled Release, 155, 344, 10.1016/j.jconrel.2011.06.004 · DOI
- Wang, 2010, Nanomedicine, 5, 563, 10.2217/nnm.10.30 · DOI
- Hartner, 2009, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol., 1, 530
- Hsiao, 2008, Small, 4, 1445, 10.1002/smll.200701316 · DOI
- Tian, 2007, Angew. Chem., Int. Ed., 46, 962, 10.1002/anie.200603917 · DOI
- Lu, 2007, Small, 3, 1341, 10.1002/smll.200700005 · DOI
- Meng, 2010, ACS Nano, 4, 4539, 10.1021/nn100690m · DOI
- Platt, 2008, Mol. Pharmaceutics, 5, 474, 10.1021/mp800024g · DOI
- Hoffman, 2008, J. Controlled Release, 132, 153, 10.1016/j.jconrel.2008.08.012 · DOI
- Lu, 2010, Small, 6, 1794, 10.1002/smll.201000538 · DOI
- Zhu, 2010, J. Phys. Chem. C, 114, 16382, 10.1021/jp106685q · DOI
- Pasqua, 2007, Microporous Mesoporous Mater., 103, 166, 10.1016/j.micromeso.2007.01.045 · DOI
- Brevet, 2009, Chem. Commun., 1475, 10.1039/b900427k · DOI
- Fang, 2012, Chem.–Eur. J., 18, 7787, 10.1002/chem.201200023 · DOI
- Cheng, 2010, J. Mater. Chem., 20, 6149, 10.1039/c0jm00645a · DOI
- Tsai, 2009, J. Mater. Chem., 19, 5737, 10.1039/b905158a · DOI
- Hua, 1993, J. Cell Sci., 106, 365, 10.1242/jcs.106.1.365 · DOI
- Knudson, 1993, FASEB J., 7, 1233, 10.1096/fasebj.7.13.7691670 · DOI
- Rivkin, 2010, Biomaterials, 31, 7106, 10.1016/j.biomaterials.2010.05.067 · DOI
- Lee, 2009, Macromol. Biosci., 9, 336, 10.1002/mabi.200800229 · DOI
- Lee, 2011, ACS Nano, 5, 6138, 10.1021/nn2017793 · DOI
- Ma, 2012, J. Mater. Chem., 22, 5615, 10.1039/c2jm15489g · DOI
- Yang, 2006, J. Am. Chem. Soc., 128, 10460, 10.1021/ja0619049 · DOI
- Beck, 1992, J. Am. Chem. Soc., 114, 10834, 10.1021/ja00053a020 · DOI
- Choi, 2009, J. Mater. Chem., 19, 4102, 10.1039/b900456d · DOI
- Lim, 2011, Biomaterials, 32, 7941, 10.1016/j.biomaterials.2011.06.077 · DOI
- Muroya, 1999, Colloids Surf., A, 157, 147, 10.1016/S0927-7757(99)00054-0 · DOI
- Sicinska, 1993, Carbohydr. Res., 242, 29, 10.1016/0008-6215(93)80020-F · DOI
- Al-Qadi, 2011, Carbohydr. Polym., 86, 25, 10.1016/j.carbpol.2011.03.022 · DOI
- Zhao, 2009, Toxicol. Appl. Pharmacol., 241, 163, 10.1016/j.taap.2009.08.010 · DOI
Cited by
Sorted by citations
Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine
Mattheolabakis, G., Milane, L., Singh, A., & Amiji, M. M. (2015) · Journal of Drug Targeting · doi:10.3109/1061186x.2015.1052072 · Cited by 597
Hoarau-Véchot, J., Rafii, A., Touboul, C., & Pasquier, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010181 · Cited by 489
Strategic approaches for colon targeted drug delivery: an overview of recent advancements
Lee, S. H., Bajracharya, R., Min, J. Y., Han, J.-W., Park, B. J., & Han, H.-K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12010068 · Cited by 318
Internal stimuli-responsive nanocarriers for drug delivery: Design strategies and applications
Liu, M., Du, H., Zhang, W., & Zhai, G. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.11.030 · Cited by 235
Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment
Choukaife, H., Seyam, S., Alallam, B., Doolaanea, A. A., & Alfatama, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s375229 · Cited by 127
Metadata
- Authors
- Yu, M., Jambhrunkar, S., Thorn, P., Chen, J., Gu, W., & Yu, C.
- Venue
- Nanoscale
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 5
- Issue
- 1
- Pages
- 178-183
- ISSN
- 2040-3364
- 2040-3372
- Cited by
- 316
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review